ORTEXORTEX News
Tracking ARR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AR
Earnings PreviewARR

ARR Lags Peers as Shorts Pull Back Before the Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 22 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ARMOUR Residential REIT is the most shorted stock in its peer group by a wide margin heading into Wednesday's earnings report. Short interest runs at 13.5% of the free float, well above the levels seen at close peers AGNC, NLY and DX. ARR also stands apart on price: the stock fell 5.9% over the past week against a median of roughly flat for those same names, which gained between 0.7% and 2.2% over the same period.

The short positioning has been unwinding, however. Shares short peaked near 17.4 million around October 8 and have since dropped to just over 15 million. The month-on-month decline is roughly 9%. Borrow conditions reflect the same retreat: cost to borrow spiked to 16.8% on October 15 before collapsing to 2.68% by October 20, and availability has loosened substantially, rising 39% on the week to 81.5%. That sequence points to covering rather than fresh pressure. The ORTEX short score has pulled back to 67 from a peak of 75, and the put/call ratio at 0.66 sits fractionally below its 20-day average, meaning options traders are not adding directional conviction ahead of the release.

The insider register adds a small wrinkle. Co-Chief Investment Officer Sergey Losyev made an open-market purchase of 725 shares on September 29, a modest but discretionary buy at $13.91. That came shortly after Chairman Daniel Staton sold 35,583 shares at $15.86 on September 10, a transaction worth $564,000. The net 90-day insider flow is modestly negative at roughly $554,000, driven primarily by the Staton sale rather than any broad retreat by management.

Analyst coverage carries a note of caution on recency: the most recent changes date to late April 2026, with UBS holding a Neutral rating and a $18.00 target while Jones Trading maintained Buy with a $19.00 target. At the current price of $12.81, both targets imply meaningful upside, though the price-to-book of 0.83 and the stock's 13% decline over the past month suggest the market is discounting those views. The bull argument centres on potential book value appreciation if MBS spreads tighten further. The bear argument points to the compression in net interest spread, prepayment risk from any Fed re-entry into the agency MBS market, and a rate environment that continues to pressure reinvestment yields.

The print will test whether ARMOUR's book value held up through the quarter and whether the dividend remains covered, the two numbers that tend to move the stock in an agency REIT reporting cycle more than any headline earnings figure.

Stocks in this article

See the live data behind this article on ORTEX.

Open ARR on ORTEX →

How this article was generated

Generated
22 Oct 2026, 04:19
Data as of
22 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.